Literature DB >> 20855556

Delay of 2 or 6 weeks adversely affects the functional outcome of augmented primary repair of the porcine anterior cruciate ligament.

Elise M Magarian1, Braden C Fleming, Sophia L Harrison, Ashley N Mastrangelo, Gary J Badger, Martha M Murray.   

Abstract

BACKGROUND: Enhanced primary anterior cruciate ligament repair, in which suture repair is performed in conjunction with a collagen-platelet composite to stimulate healing, is a potential new treatment option for anterior cruciate ligament injuries. Previous studies have evaluated this approach at the time of anterior cruciate ligament disruption. HYPOTHESIS: Delaying surgery by 2 or 6 weeks would have a significant effect on the functional outcome of the repair. STUDY
DESIGN: Controlled laboratory study.
METHODS: Sixteen female Yorkshire pigs underwent staged, bilateral surgical anterior cruciate ligament transections. Anterior cruciate ligament transection was initially performed on 1 knee and the knee closed. Two or 6 weeks later, enhanced primary repair was performed in that knee while the contralateral knee had an anterior cruciate ligament transection and immediate repair. Biomechanical parameters were measured after 15 weeks in vivo to determine the effect of delay time relative to immediate repair on the healing response.
RESULTS: Yield load of the repairs at 15 weeks was decreased by 40% and 60% in the groups where repair was delayed for 2 and 6 weeks, respectively (P = .01). Maximum load showed similar results (55% and 60% decrease in the 2- and 6-week delay groups, respectively; P = .011). Linear stiffness also was adversely affected by delay (50% decrease compared with immediate repair after either a 2- or 6-week delay, P = .011). Anterior-posterior laxity after 15 weeks of healing was 40% higher in knees repaired after a 2-week delay and 10% higher in those repaired after a 6-week delay (P = .012) when tested at 30° of flexion, but was not significantly affected by delay when tested at 60° or 90° (P = .21).
CONCLUSION: A delay between anterior cruciate ligament injury and enhanced primary repair has a significant negative effect on the functional performance of the repair. CLINICAL RELEVANCE: As future investigations assess new techniques of anterior cruciate ligament repair, the timing of the repair should be considered in the design and the interpretation of experimental studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855556      PMCID: PMC2996471          DOI: 10.1177/0363546510377416

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  21 in total

1.  Histological changes in the human anterior cruciate ligament after rupture.

Authors:  M M Murray; S D Martin; T L Martin; M Spector
Journal:  J Bone Joint Surg Am       Date:  2000-10       Impact factor: 5.284

2.  Measurement of anterior-posterior knee laxity: a comparison of three techniques.

Authors:  Braden C Fleming; Bjarne Brattbakk; Glenn D Peura; Gary J Badger; Bruce D Beynnon
Journal:  J Orthop Res       Date:  2002-05       Impact factor: 3.494

3.  Cell outgrowth from the human ACL in vitro: regional variation and response to TGF-beta1.

Authors:  Martha Meaney Murray; Rebecca Bennett; Xiuying Zhang; Myron Spector
Journal:  J Orthop Res       Date:  2002-07       Impact factor: 3.494

4.  The effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen-GAG scaffold.

Authors:  M Meaney Murray; K Rice; R J Wright; M Spector
Journal:  J Orthop Res       Date:  2003-03       Impact factor: 3.494

5.  Rehabilitation after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind comparison of programs administered over 2 different time intervals.

Authors:  Bruce D Beynnon; Benjamin S Uh; Robert J Johnson; Joseph A Abate; Claude E Nichols; Braden C Fleming; A Robin Poole; Harald Roos
Journal:  Am J Sports Med       Date:  2005-03       Impact factor: 6.202

6.  A functional comparison of animal anterior cruciate ligament models to the human anterior cruciate ligament.

Authors:  J W Xerogeanes; R J Fox; Y Takeda; H S Kim; Y Ishibashi; G J Carlin; S L Woo
Journal:  Ann Biomed Eng       Date:  1998 May-Jun       Impact factor: 3.934

7.  Bone-to-bone fixation enhances functional healing of the porcine anterior cruciate ligament using a collagen-platelet composite.

Authors:  Martha M Murray; Elise Magarian; David Zurakowski; Braden C Fleming
Journal:  Arthroscopy       Date:  2010-06-11       Impact factor: 4.772

8.  The effect of thrombin on ACL fibroblast interactions with collagen hydrogels.

Authors:  M M Murray; B Forsythe; F Chen; S J Lee; J J Yoo; A Atala; A Steinert
Journal:  J Orthop Res       Date:  2006-03       Impact factor: 3.494

9.  The migration of cells from the ruptured human anterior cruciate ligament into collagen-glycosaminoglycan regeneration templates in vitro.

Authors:  M M Murray; M Spector
Journal:  Biomaterials       Date:  2001-09       Impact factor: 12.479

10.  High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes.

Authors:  A von Porat; E M Roos; H Roos
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

View more
  19 in total

1.  Fresh versus frozen engineered bone-ligament-bone grafts for sheep anterior cruciate ligament repair.

Authors:  Vasudevan D Mahalingam; Nilofar Behbahani-Nejad; Elizabeth A Ronan; Tyler J Olsen; Michael J Smietana; Edward M Wojtys; Deneen M Wellik; Ellen M Arruda; Lisa M Larkin
Journal:  Tissue Eng Part C Methods       Date:  2014-12-29       Impact factor: 3.056

2.  Updates in biological therapies for knee injuries: anterior cruciate ligament.

Authors:  Carlos Eduardo da Silveira Franciozi; Sheila Jean McNeill Ingham; Guilherme Conforto Gracitelli; Marcus Vinicius Malheiros Luzo; Freddie H Fu; Rene Jorge Abdalla
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

3.  Expression of modulators of extracellular matrix structure after anterior cruciate ligament injury.

Authors:  Carla M Haslauer; Benedikt L Proffen; Victor M Johnson; Martha M Murray
Journal:  Wound Repair Regen       Date:  2014 Jan-Feb       Impact factor: 3.617

4.  Use of a bioactive scaffold to stimulate anterior cruciate ligament healing also minimizes posttraumatic osteoarthritis after surgery.

Authors:  Martha M Murray; Braden C Fleming
Journal:  Am J Sports Med       Date:  2013-07-15       Impact factor: 6.202

Review 5.  The potential for primary repair of the ACL.

Authors:  Patrick Vavken; Martha M Murray
Journal:  Sports Med Arthrosc Rev       Date:  2011-03       Impact factor: 1.985

6.  Bio-enhanced repair of the anterior cruciate ligament.

Authors:  Benedikt L Proffen; Jakob T Sieker; Martha M Murray
Journal:  Arthroscopy       Date:  2015-01-14       Impact factor: 4.772

7.  Rise of the Pigs: Utilization of the Porcine Model to Study Musculoskeletal Biomechanics and Tissue Engineering During Skeletal Growth.

Authors:  Stephanie G Cone; Paul B Warren; Matthew B Fisher
Journal:  Tissue Eng Part C Methods       Date:  2017-09-01       Impact factor: 3.056

8.  Biology of anterior cruciate ligament injury and repair: Kappa delta ann doner vaughn award paper 2013.

Authors:  Martha Meaney Murray; Braden C Fleming
Journal:  J Orthop Res       Date:  2013-07-01       Impact factor: 3.494

9.  Collagen application reduces complication rates of mid-substance ACL tears treated with dynamic intraligamentary stabilization.

Authors:  Dimitrios S Evangelopoulos; Sandro Kohl; Stefan Schwienbacher; Benjamin Gantenbein; Aristomenis Exadaktylos; Sufian S Ahmad
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-12       Impact factor: 4.342

10.  Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury.

Authors:  C M Haslauer; K A Elsaid; B C Fleming; B L Proffen; V M Johnson; M M Murray
Journal:  Osteoarthritis Cartilage       Date:  2013-09-13       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.